Buckingham Capital Management (Ohio)’s Teva Pharmaceuticals TEVA Stock Holding History

Buckingham Capital Management (Ohio)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,420	Closed	-$203K	–	145
2016 Q3	$203K	Sell	4,420 -400	-8%	-$20.9K	0.05%	140
2016 Q2	$242K	Hold	4,820	–	–	0.06%	142
2016 Q1	$258K	Sell	4,820 -50	-1%	-$2.93K	0.07%	147
2015 Q4	$320K	Sell	4,870 -450	-8%	-$27.8K	0.09%	150
2015 Q3	$300K	Sell	5,320 -400	-7%	-$25.9K	0.09%	155
2015 Q2	$338K	Buy	5,720 +30	+0.5%	+$1.85K	0.09%	157
2015 Q1	$354K	Hold	5,690	–	–	0.1%	153
2014 Q4	$327K	Sell	5,690 -200	-3%	-$11.1K	0.1%	153
2014 Q3	$317K	Sell	5,890 -750	-11%	-$39.7K	0.1%	156
2014 Q2	$348K	Sell	6,640 -1,305	-16%	-$66.7K	0.11%	149
2014 Q1	$420K	Sell	7,945 -1,979	-20%	-$91.5K	0.14%	142
2013 Q4	$398K	Sell	9,924 -220	-2%	-$8.66K	0.14%	141
2013 Q3	$386K	Sell	10,144 -475	-4%	-$18.5K	0.16%	135
2013 Q2	$416K	Buy	+10,619	New	+$414K	0.17%	129

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Buckingham Capital Management (Ohio)'s TEVA Position: Q4 2016 in Review

Buckingham Capital Management (Ohio) sold out of Teva Pharmaceuticals (TEVA) in Q4 2016, closing a stake of 4,420 shares — an estimated $203K sold.

Buckingham Capital Management (Ohio) first reported a position in TEVA in Q2 2013 and held it in 14 quarters. The position peaked at $420K in Q1 2014. 737 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Buckingham Capital Management (Ohio) reported no remaining Teva Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Buckingham Capital Management (Ohio) sold 4,420 Teva Pharmaceuticals shares in Q4 2016, an estimated $203K.
Buckingham Capital Management (Ohio) first reported a position in Teva Pharmaceuticals in Q2 2013 and held it in 14 quarters.
Buckingham Capital Management (Ohio)'s Teva Pharmaceuticals position peaked at $420K in Q1 2014.
737 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2016.

Based on Buckingham Capital Management (Ohio)'s 13F filing for Q4 2016, filed 8 Feb 2017.